CN Patent

CN116710078A — 森塔纳法啶药物制剂及其制备和使用方法

Assigned to Otsuka Pharmaceutical Co Ltd · Expires 2023-09-05 · 3y expired

What this patent protects

本发明公开了包含森塔纳法啶(centanafadine)(CTN)或其药学上可接受的盐和赋形剂的药物制剂，以及相关的制备和使用方法。

USPTO Abstract

本发明公开了包含森塔纳法啶(centanafadine)(CTN)或其药学上可接受的盐和赋形剂的药物制剂，以及相关的制备和使用方法。

Drugs covered by this patent

cysteamine-bitartrate (CYSTEAMINE BITARTRATE)

Patent Metadata

Patent number: CN116710078A
Jurisdiction: CN
Classification: —
Expires: 2023-09-05
Drug substance claim: No
Drug product claim: No
Assignee: Otsuka Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.